Los Angeles, CA, United States of America

Jishu Shi

This inventor holds 5 USPTO granted patents. Top assignee: Kansas State University Research Foundation. Active years: 1998-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jishu Shi. Retrieved from https://idiyas.com/inventor/jishu-shi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 80.0

Average Co-Inventor Count = 2.1

ph-index = 2

Forward Citations = 37(Granted Patents)


Location History:

  • Los Angeles, CA (US) (2000 - 2006)
  • Manhattan, KS (US) (1998 - 2018)

Company Filing History:


Years Active: 1998-2018

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Jishu Shi: Innovator in Vaccine Adjuvants and Peptide Research

Introduction

Jishu Shi is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of pharmaceutical and veterinary compositions, particularly in the development of vaccine adjuvants. With a total of 5 patents to his name, his work focuses on enhancing immune responses through innovative peptide-based solutions.

Latest Patents

One of Jishu Shi's latest patents involves the creation of vaccine adjuvants derived from self-assembling peptides. These pharmaceutical compositions are designed to treat or protect subjects from various conditions using peptide-based adjuvants. The adjuvants consist of a peptide that features a hydrophobic region, a turning region, and a hydrophilic region. Notably, the turning region includes specific amino acid residues, GSII (SEQ ID NO: 10). This innovative approach aims to immunopotentiate active agents by improving the immune response to them.

Another significant patent focuses on synthetic peptides that inhibit leukocyte superoxide anion production and attract leukocytes. This patent discloses methods for utilizing specific peptides, including the proline-arginine (PR)-rich antimicrobial peptide known as PR-39 and its truncated analogs. These peptides serve as medicaments that combat infections by drawing leukocytes to wound sites while minimizing tissue damage caused by excessive oxygen radicals produced by these leukocytes.

Career Highlights

Jishu Shi is affiliated with the Kansas State University Research Foundation, where he continues to advance his research in peptide technology and vaccine development. His work has garnered attention for its potential applications in improving health outcomes through innovative therapeutic strategies.

Collaborations

Some of Jishu Shi's notable coworkers include Frank Blecha and Christopher R. Ross. Their collaborative efforts contribute to the ongoing research and development in the field of peptide-based therapies.

Conclusion

Jishu Shi stands out as an influential inventor in the realm of vaccine adjuvants and peptide research. His innovative patents and contributions to the scientific community highlight the importance of advancing medical technologies for better health solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…